-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On May 14, 2021, Bojian Company announced that Fampridine Sustained-Release Tablets have been officially approved by the National Medical Products Administration for the improvement of multiple sclerosis (hereinafter referred to as MS) combined with walking disorder (EDSS score 4-7) in adult patients Walking ability.
The drug review of the National Medical Products Administration referred to three global phase 3, randomized, double-blind, placebo-controlled confirmatory studies.
In May 2018, MS was included in the "First List of Rare Diseases.